MAP PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
MAP PHARMACEUTICALS, INC. reported Increase (Decrease) in Deferred Revenue of $54.15 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2012-09-30 was -$878.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2012-06-30 was -$878.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2012-03-31 was -$1.03M, a 101.73% decline year-over-year.
- MAP PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2011-12-31 was -$837.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2011 was $56.93M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 96 month | Increase (Decrease) in Deferred Revenue 96 month as first filed | Increase (Decrease) in Deferred Revenue 99 month | Increase (Decrease) in Deferred Revenue 99 month as first filed | Increase (Decrease) in Deferred Revenue 102 month | Increase (Decrease) in Deferred Revenue 105 month | Increase (Decrease) in Deferred Revenue 108 month | Increase (Decrease) in Deferred Revenue 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | -$878.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$1.76M derived: sum of 2 quarters · filed 2012-11-06 | -$2.78M 10-Q · filed 2012-11-06 | -$3.62M derived: sum of 4 quarters · filed 2012-11-06 | $54.15M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | -$878.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$1.91M 10-Q · filed 2012-07-27 | -$2.74M derived: sum of 3 quarters · filed 2012-07-27 | -$3.58M derived: sum of 4 quarters · filed 2012-11-06 | $55.02M 10-Q · filed 2012-07-27 | |||||||||
| 2012-03-31 | -$1.03M 10-Q · filed 2012-05-08 | -$1.86M derived: sum of 2 quarters · filed 2012-05-08 | -$2.70M derived: sum of 3 quarters · filed 2012-11-06 | -$3.54M derived: sum of 4 quarters · filed 2012-11-06 | $55.90M 10-Q · filed 2012-05-08 | |||||||||
| 2011-12-31 | -$837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$1.68M derived: sum of 2 quarters · filed 2012-11-06 | -$2.51M derived: sum of 3 quarters · filed 2012-11-06 | $56.93M 10-K · filed 2012-03-30 | $56.93M 10-K · filed 2012-03-30 | |||||||||
| 2011-09-30 | -$838.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$1.68M derived: sum of 2 quarters · filed 2012-11-06 | $57.77M 10-Q · filed 2012-11-06 | $18.46M 10-Q · filed 2011-11-08 | $57.77M 10-Q/A · filed 2012-03-30 | $18.46M 10-Q · filed 2011-11-08 | ||||||||
| 2011-06-30 | -$838.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $58.60M 10-Q · filed 2012-07-27 | $22.32M 10-Q · filed 2011-08-08 | $58.60M 10-Q/A · filed 2012-03-30 | $22.32M 10-Q · filed 2011-08-08 | |||||||||
| 2011-03-31 | $59.44M 10-Q · filed 2012-05-08 |